SP1 tethers NR2F2 to drive atrial cardiomyocyte identity
This study reveals that the transcription factor SP1 physically tethers NR2F2 to drive human atrial cardiomyocyte identity, a mechanism uncovered through a novel systematic approach integrating single-cell multi-omics, AlphaFold predictions, and experimental validation in human iPSC-derived cells.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human heart is the first organ to take shape in a developing embryo, and it does so by dividing its labor into distinct chambers: the upper atria and the lower ventricles. While these chambers work together to pump blood, they are built from cells with different jobs, shapes, and electrical rhythms. This specialization is not random; it is directed by a complex set of instructions within the cell's DNA. These instructions are managed by proteins called transcription factors, which act like switches, turning specific genes on or off to tell a cell whether to become part of the upper or lower chamber. For decades, scientists have known that a specific protein called NR2F2 is essential for telling heart cells to become atrial. However, the exact mechanism by which this protein operates in the human heart has remained a mystery, particularly because the instructions in human development often differ from those found in animal models. Understanding these precise molecular switches is crucial, as errors in this process can lead to serious congenital heart defects.
In a new study, researchers at the University of Virginia set out to map the specific gene networks that guide human fetal heart cells to their final identity. Instead of looking at genes in isolation, they used a systematic approach to compare two different ways of viewing the heart's genetic landscape. One method looked at the genes that were actually being read by the cells at that moment, while the other method examined the physical accessibility of the DNA, identifying which regions were open for business. By comparing these two perspectives using data from human fetal hearts collected at various stages of development, the team discovered a surprising twist in how the heart decides its shape. They found that the key protein NR2F2 does not bind directly to the DNA of the genes it needs to activate. Instead, it relies on a partner.
The researchers identified a different protein, known as SP1, as the essential bridge that allows NR2F2 to do its work. In the developing human heart, the DNA regions where NR2F2 needs to attach are often closed off or inaccessible. The study suggests that NR2F2 cannot reach these targets on its own. Instead, it physically latches onto SP1, which is already bound to the DNA. This partnership allows NR2F2 to be pulled to the correct location, effectively tethering it to the genes that define the atrial identity. To confirm this, the team used advanced computer modeling to predict the physical shape of these proteins interacting with DNA. The simulations showed that NR2F2 and SP1 form a stable, compact complex when they bind together at the gene sites, a configuration that would not exist if either protein acted alone.
To prove that this interaction is not just a computer prediction but a biological reality, the researchers turned to human stem cells grown in the lab. They guided these cells to become heart muscle cells and then specifically reduced the levels of SP1. When SP1 was removed, the cells failed to develop the characteristics of atrial muscle, even though NR2F2 was still present. The cells lost their atrial identity, demonstrating that SP1 is absolutely necessary for the process. Furthermore, the team used a technique that detects when two proteins are touching each other inside the cell nucleus. They observed that NR2F2 and SP1 were physically touching in the nuclei of cells that were successfully becoming atrial muscle, and this contact disappeared when SP1 was reduced.
This work reveals that the rules governing human heart development are more intricate than previously thought. The study rules out the idea that NR2F2 acts as a solitary commander binding directly to DNA to create the upper chambers. Instead, it establishes that NR2F2 functions as part of a team, requiring the physical support of SP1 to reach its targets. By comparing gene networks constrained by actual DNA accessibility against those based on general gene promoters, the researchers uncovered a cooperative mechanism that was invisible to traditional methods. This discovery highlights that in the complex world of human development, critical proteins often rely on partners to execute their instructions, a finding that helps explain how the heart's unique chambers are formed and may offer new insights into why certain heart defects occur when these partnerships fail.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.